Home - Doctors List - Doctor's Details
Book Appointment 
Doctor available in
-
ILS Hospitals, Saltlake -
ILS Hospitals, Dumdum
-
ILS Hospitals, Howrah
-
ILS Hospitals, Agartala
-
ILS Hospitals, Raipur
Description
Education and Training
- MBBS, Pt. JNM Medical College Raipur C.G, 1998
- DNB Radiodiagnosis, National Board of Examinations New delhi, 2005
- DMRD, Lokmanya Tilak Municipal Medical College Mumbai, 2003
- DMRE, College of Physicians & Surgeons Of Bombay, 2004
Fellowships
- Fellowship in Dept. Of Interventional Radiology, Tata Memorial Hospital Mumbai, 2019
- Fellowship in Dept. Of Diagnostic Radiology, MD Anderson Cancer Center, Texas, US, 2019
Awards, Honors & Recognitions
- Contributed a chapter(Imaging in Oral Cavity Carcinoma) as author.
- Participated in organisation of SOIICON 2019
- Part of organizing committee XIIIth interventional radiology group meet in july 2016
- Participation in Formative assessment 2015,2017, and 2019 as examiner DNB Radiodiagnosis.
Area(S) Of Interest
- Head & Neck Radiology
- Neuroradiology
- Musculoskeletal Radiology
RESEARCH PROJECT
- Guide in DNB thesis: “Radiopathological correlation of tumor regression in rectal carcinoma”.
- Guide in DNB thesis: “Role of DWI in different neoplasm in skeletal musculature”.
- Guide in DNB thesis: “Role of ADC values in assessing response to chemo radiotherapy in Cervix Cancer and identifying residual disease”.
- Co-guide in DNB thesis:“Importance of DWI in detecting prostate cancer”.
- Co-guide in DNB thesis “Role of diffusion weighted MRI imaging in differentiation of residual or recurrent head and neck malignancies and post treatment changes in comparison with histopathology /cytology findings.
- RARE CASE OF SYNOVIAL CHONDROMATOSIS PRESENTING AS JAW PAIN international Journal of Current Research Vol. 10, Issue, 03, pp.66433-66435, March, 2018, Dr. Vivek Mahawar, Dr. Ankush Jajodia and Dr. Venkata Pradeep Babu Koyyala, 2018
- Case report: Rare case of an isolated myeloid sarcoma presenting as dysphagia. Asian J Oncol 2018;4:30-3. Rishu Sangal, Vivek Mahawar1, Ankush Jajodia1.
- Case report: Role of Diagnostic Block in S1 radiculopathy in a patient of carcinoma rectum with leg pain published in JORAPAIN- International Journal on RecentAdvances in Pain in January-April 2018;4(1):44-46. Mahawar B, Mahawar V, Sahi M
- Case report: Methotrexate induced neurotoxicity: A stroke mimic, International Journal of Medical and Health Research, ISSN: 2454-9142. Impact Factor: RJIF 5.54. www.medicalsciencejournal.com. Volume 4; Issue 4; April 2018; Page No. 32-34. Dr. Wasif Bashir, Dr. Ankush Jajodia, Dr. Rishab Agarwal, Dr. K Venkata Pradeep Babu*, Dr. Vivek Mahawar,
- Case Report: Recurrent carcinoma rectum patient presented with S 1 radiculopathy- An Unusual Presentation- Case report published in International Journal Of Science And Research Methodology (IJSRM) in April 2018 Vol:9, Issue:2 Bablesh Mahawar1, Vivek Mahawar2 , Ankush Jajodia3.
- Is chest X-ray an adequate modality for confirming position of central venous catheter in patients with malignant pleural effusion : published in international journal of scientific research Volume-7/Issue-9/September2018/ISSN No. 2277-8179/IF4.758/IC value :93.98. Dr. Bablesh Mahawar, Dr Vivek Mahawar, Dr Ankush Jajodia,
- Letter to editor -Excellent response of solifenacin in chemotherapy induced hemorrhagiccystitis in a child with Non- Hodgkin’s Lymphoma. South Asian J Cancer. Jul-Sep 2018;7(3):213. doi: 10.4103/sajc.sajc_145_18.Mahawar B, Mahawar V, Jajodia A, Babu Koyyala VP.
- Fluoroscopic Splanchnic Neurolysis – Effective & Economical Than Endoscopic USG Celiac Neurolysis- Experience in A Series of Cases published in IJRSM in April 2018 Vol: 9, Issue: 2. Bablesh Mahawar, Vivek Mahawar, Ankush Jajodia , Venkata Pradeep Babu Koyyala
- Role of ADC values in assessing clinical response and identifying residual disease post-chemo radiation in uterine cervix cancer. Indian J Radiol Imaging. 2019 Oct-Dec; 29(4): 404–411. Ankush Jajodia, Vivek Mahawar, Arvind K Chaturvedi, Avinash Rao, Rishu Singla, Swarupa Mitra, Sumit Goyal, Sikha Kesan, Sunil Pasricha, Udip Maheshwari, Rupal Tripathi and Venkata Pradeep Babu Koyyala.
- Patterns of brain metastasis in anaplastic lymphoma kinase – rearranged and epidermal growth factor receptor-mutated lung cancer patients in magnetic resonance imaging South Asian J Cancer. Jul-Sep 2019;8(3):189-190. doi: 10.4103/sajc.sajc_98_18.Ullas Batra 1, Vivek Mahawar 1, Ankush Jajodia 1, Avinash Razdan 1
- Comparing the diagnostic efficacy of Full Field Digital Mammography with Digital Breast Tomosynthesis for diagnostic and screening purposes using BIRADS score in a tertiary cancer care hospital” – Indian J Radiol Imaging. 2018 Jan-Mar; 28(1): 115–122. doi: 10.4103/ijri.IJRI_107_17 Divya Singla, Arvind K. Chaturvedi,1 Abhinav Aggarwal,2 S. A. Rao,1 Dibyamohan Hazarika, Vivek Mahawar
- Surgical Treatment of Eloquent Area Metastatic Brain Lesions from Unusual Primaries: Early Outcome. Open Access J Neurol Neurosurg. 2018; 9(1): 555753. DOI: 10.19080/OAJNN.2018.09.555753 Jaggi Ramandeep S1* and Mahawar Vivek2.
- “Preliminary Experience with Intranodal lymphangiography (LAG) with lipiodol for postoperative persistent chylous ascites” – Abstract for consideration at the Digestive Disease Interventions 2016 Dr. Abhishek Bansal*, Dr. D.M. Hazarika*, Dr. Vivek Mahawar*, Dr. SA. Rao*, Dr. Arvind K. Chaturvedi*, Dr. Rupinder Sekhon#, Dr. Sudhir Rawal#.
- 117PCorrelation of MRI derived parameters and SUV uptake obtained from FDG- PET-CT with human papillomavirus status in oropharyngeal squamous cell carcinomas November 2019 Annals of Oncology 30 DOI: 10.1093/annonc/mdz413.121 S. Goyal1, V.P.B. Koyyala, A. Jajodia, A. Chaturvedi, M. Gairola, A. Rao, M. Sharma,S. Pasricha, P. Alhawat, V. Mahawar, B. Amrith, R. Tripathi
- Value of diffusion MR imaging in differentiation of recurrent head and neck malignancies from post treatment changes Oral Oncology Volume 96, September 2019, Pages 89-96.AnkushJajodia DeepaAggarwal ArvindK.Chaturvedi AvinashRao, VivekMahawar MunishGairola MuditAgarwal SumitGoyal Venkata Pradeep Babu Koyyala SunilPasricha RupalTripathi.
- Role of ADC values in assessing response after chemoradiotherapy in cervix cancer and in identifying residual disease published in annals of oncology in Annals of Oncology Volume 30, Supplement 9, November 2019, Page ix84 V.P.B.Koyyala1 A.Jajodia1 A.K.Chaturvedi 1 V.Mahawar1M.Sharma1P.Goyal1V.Talwar2S.Goyal1D.C.Doval2e
- Role of Advanced Imaging in Gasserian Neurolysis in Head and Neck Cancer with Skull Base Invasion published in Nov 2019 in Asian journal of oncology. DOI: 10.1055/s-0039-3401332 Bablesh Mahawar Vivek Mahawar.
- Role of pulsed radiofrequency neuromodulation adjacent to lumbar dorsal root ganglion in bone metastatic cancer pain, January 2019, Indian Journal of Pain 33(2):100, DOI: 10.4103/ijpn.ijpn_10_19, Bablesh Mahawar, Vivek Mahawar, Ravi Shankar Sharma
- Patterns of Central Nervous System Metastases in EGFR Mutated or ALK Rearranged Non Small Cell Lung Cancer Patients October 2018 Journal of Thoracic Oncology 13(10):S697 DOI: 10.1016/j.jtho.2018.08.1138 Manish Sharma Ullas Batra Parveen Jain V. Mahawar Ankush Jajodia.
- Role of 18F-Flurodeoxyglucose Positron-Emission Tomography/Computed Tomography in the Evaluation of Early Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Triple-Negative Breast Cancer Indian J Nucl Med. 2020 Apr-Jun; 35(2): 105–109. Published online 2020 Mar 12. doi: 10.4103/ijnm.IJNM_210_19 Bina Basnet, Pankaj Goyal,1 Vivek Mahawar,2 Sneha Jatan Bothra,1 Chaturbhuj Agrawal,1 Bikash Bikram Thapa,3 Vineet Talwar,1 Parveen Jain,1 Venkata Pradeep Babu Koyyala,1 Varun Goel,1 Ullas Batra,1 and Dinesh Chandra Doval1.
STUDIES LIST
Participated as Radiologist in various clinical drug trials in RGCIRC
| S.No | Study Title | Role | Sponsor | Study Status |
|---|---|---|---|---|
| 1. | A Phase 3, Multicenter, Multinational, Randomized, Open-Label, Parallel-Arm Study Of Avelumab* (Msb0010718c) Plus Best Supportive Care Versus Best Supportive Care Alone As A Maintenance Treatment In Patients With Locally Advanced Or Metastatic Urothelial Cancer Whose Disease Did Not Progress After Completion Of First-Line Platinum-Containing Chemotherapy (B9991001) | CO-I | Pfizer | Ongoing |
| 2. | “A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone in Patients with Unresectable Locally Advanced or Metastatic Urothelial Cancer” (Nile) | CO-I | Astrazeneca | Ongoing |
| 3. | BYLieve: A phase II, multicenter, open-label, two-cohort, non-comparative study to assess the efficacy and safety of alpelisib plus fulvestrant or letrozole in patients with PIK3CA mutant, hormone receptor (HR) positive, HER2- negative advanced breast cancer (aBC), who have progressed on or after CDK 4/6 inhibitor treatment. (CBYL719X2402) | CO-I | Novartis | Ongoing |
| 4. | A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab (Anti-Pd-L1 Antibody) As Adjuvant Therapy After Definitive Local Therapy in Patients with High-Risk Locally Advanced Squamous Cell Carcinoma of The Head and Neck (WO40242) | Co-I | Roche | Closed |
| 5. | A Prospective, Open-label, Phase 4 Study to Evaluate the Safety of Pembrolizumab (KEYTRUDA®) in Subjects with Unresectable or Metastatic Melanoma or PD-L1 positive Non-small Cell Lung Cancer (NSCLC) in India (Keynote-593) | Co-I | Merck | Ongoing |
| 6. | “An Indian Multicentric Open Label Prospective Phase IV Study to Evaluate Safety and Efficacy of Trastuzumab in Her2 Positive, Node Positive Or High Risk Node Negative Breast Cancer as Part of a Treatment Regimen consisting Of Doxorubicin, Cyclophosphamide, with Either Docetaxel or Paclitaxel (AC—TH) or Docetaxel And Carboplatin (TCH)” (ML28714) | CO-I | Roche | Ongoing |
| 7. | A multicenter, open-label, single-arm, phase IV study of Trastuzumab Emtansine in Indian Patients with HER2 positive unresectable locally advanced or metastatic breast cancer who have received prior treatment with trastuzumab and a taxane (ML29662) | CO-I | Roche | Ongoing |
| 8. | A PHASE III, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ATEZOLIZUMAB COMPARED WITH CHEMOTHERAPY IN PATIENTS WITH TREATMENT-NAÏVE ADVANCED OR RECURRENT (STAGE IIIB NOT AMENABLE FOR MULTIMODALITY TREATMENT) OR METASTATIC (STAGE IV) NON-SMALL CELL LUNG CANCER WHO ARE DEEMED UNSUITABLE FOR PLATINUM-CONTAINING THERAPY (MO29872) | Co-I | Roche | Ongoing |
| 9. | A Phase III, Global, Multicentre, randomised, double-blind, two-arm, placebo controlled study designed to evaluate the efficacy and safety of Atezolizumab (an anti-PD-L1 antibody) administered in combination with paclitaxel compared with placebo in combination with paclitaxel in patients with previously untreated, inoperable locally advanced or metastatic, centrally confirmed TNBC (MO39196) | CO-I | Roche | Ongoing |
| 10. | A Phase IV, Multicenter, Open-Label, Single-Arm Study of Pertuzumab (In Combination with Trastuzumab and Docetaxel) In First Line Treatment of Indian Patients with Her2- Positive Advanced (Metastatic or Locally Recurrent) Breast Cancer. (ML29282) | CO-I | Roche | Closed |
| 11. | CLEE011A2207 Phase II, multicenter, randomized, open-label study to evaluate the safety and efficacy of 400 mg of Ribociclib in combination with non-steroidal aromatase inhibitors for the treatment of pre- and postmenopausal women with hormone receptor-positive, her2-negative advanced breast cancer who received no prior therapy for advanced disease. | CO-I | Novartis | Ongoing |
Department
- Radiology
Education
- MBBS
- DNB(Radiodiagnosis)
- DMRD
- DMRE
Get a call back from our health advisor
Feedback From Our Patients
New beginnings filled with joy!
From Stones to Serenity!
Gratitude in Healing!
Breaking barriers together!
